Our Think Tank brings together leading experts in artificial intelligence, biotechnology, and the pharmaceutical industry, united by a shared vision: to foster innovation and the responsible development of AI. With expertise ranging from scientific and epistemological research to technology, ethics, and regulatory affairs, we collaborate to shape the future of AI-driven solutions—ensuring safety, transparency, and tangible impact across life sciences and industrial applications.
Explainambiguity Think Tank is part of the Drug Target Review Advisory Board, represented by Dr. Remco Foppen. Meet the minds redefining the future of AI in healthcare and beyond.
Dr. Remco JanGeukes Foppen
CO-FOUNDER AI and life sciences expert specializing in the pharmaceutical sector. Member of the Drug Target Review Advisory Board.
Vincenzo Gioia
CO-FOUNDER AI Innovation and Transition Manager, Senior Manager, Independent
Alessio Zoccoli
Senior Data Scientist - Tech Leader
Alberto Traverso
Head of RWE-RWD and AI clinical research | Oncology
Marcella Zucca
Senior Conversational AI
Paolo D'Ambrosio
Philosopher of science and epistemologist, specialized in philosophy of biology.
Roberta Campione
AI Strategy Manager, Service Designer and Innovator